Therapy News and Research

RSS

Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

In a new study, researchers hypothesized and developed broad-spectrum SARS-CoV-2 inhibitors, ReconnAbs, by modifying the existing non-neutralizing antibodies targeted towards the highly conserved epitopes of the SARS-CoV-2 spike (S) protein combined with a receptor-blocking component.

28 Jan 2022

Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

Researchers investigate the possible efficacy of IFN-λ in the context of SARS-CoV-2 infection in mice.

28 Jan 2022

New atlas characterizes immune cells that play a role in hemorrhagic stroke

In work that will enhance the study of such disparate diseases as stroke and dementia, researchers at UC San Francisco have catalogued all the cells that form the blood vessels of the human brain, along with their locations and the genes transcribed in each.

28 Jan 2022

Desipramine and L-cycloserine together reduce ceramide levels in the retina and enhance vision

Researchers from the University of California, Irvine have discovered that the absence of Adiponectin receptor 1 protein (AdipoR1), one of the principal enzymes regulating ceramide homeostasis in the retina, leads to an accumulation of ceramides in the retina, resulting in progressive photoreceptor cell death and ultimately vision loss.

28 Jan 2022

Photobiomodulation may accelerate the healing of skin damage from radiation therapy

Light therapy may accelerate the healing of skin damage from radiation therapy by up to 50%, according to a recent University at Buffalo-led study.

27 Jan 2022

UK's LEND program helps provide effective care for children with developmental disabilities

Here in Kentucky and across the nation, there is an increased need for a qualified workforce to better serve the growing population of children with developmental disabilities including autism spectrum disorder.

27 Jan 2022

SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows

In a 38-year-old man who manifested mild symptoms of COVID-19 for 20 days, the novel coronavirus continued to be detected in his organism and to undergo mutations for 232 days.

27 Jan 2022

Rising NO2 pollution levels in urban areas may lead to new child asthma cases

Reducing air pollution should be a crucial part of health strategies for children, as nitrogen dioxide (NO2) — a harmful pollutant emitted from burning fossil fuels — may lead to nearly 2 million new child asthma cases a year, research suggests.

27 Jan 2022

Blood proteoforms may help predict liver transplant rejection

Northwestern University scientists have discovered families of proteins in the body that could potentially predict which patients may reject a new organ transplant, helping inform decisions about care.

27 Jan 2022

Effects of multi-nutrient supplementation on COVID-19 severity in elderly patients

In a new study, researchers analyzed the effects of multi-nutrient supplementation on SARS-CoV-2 vaccine efficacy and the overall improvement of respiratory and muscle function in elderly COVID-19 patients.

27 Jan 2022

Significance of metabolic parameters in COVID-19 prognosis

In a new study, researchers evaluated the significance of metabolic parameters in determining COVID-19 prognosis.

27 Jan 2022

Drug combo delivered in a nanoparticle formulation extends the survival of mice with medulloblastoma

UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival of mice with medulloblastoma.

27 Jan 2022

Music therapy can be an attractive option to manage menopause symptoms and depressed mood

As researchers continue to seek effective treatment options for menopause symptoms as alternatives to proven pharmacologic solutions, a number of innovative therapies have been shown to improve symptoms.

27 Jan 2022

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

Death rates from ovarian cancer are predicted to fall by 17% in the UK and by 7% in EU countries in 2022 compared to 2017, according to new research published in the leading cancer journal Annals of Oncology today (Wednesday).

27 Jan 2022

Immunosuppressed patients can benefit from COVID-19 booster vaccination, study shows

Patients under immunosuppressive therapy, who do not respond to primary COVID-19 vaccination, have an increased risk for severe COVID-19 disease courses. Until now, it was not clear whether those patients at risk can benefit from an additional booster vaccination.

26 Jan 2022

Macromolecular gel with therapeutic payload could halt or slow post-traumatic osteoarthritis

Osteoarthritis affects over 32 million Americans, levying a huge cost on society. Unfortunately, other than analgesics, no pharmaceutical therapy exists that can slow or halt disease progression of a major subset of OA: post-traumatic osteoarthritis (PTOA).

26 Jan 2022

Therapy News and Research

Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

New atlas characterizes immune cells that play a role in hemorrhagic stroke

Desipramine and L-cycloserine together reduce ceramide levels in the retina and enhance vision

Photobiomodulation may accelerate the healing of skin damage from radiation therapy

UK's LEND program helps provide effective care for children with developmental disabilities

SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows

Rising NO2 pollution levels in urban areas may lead to new child asthma cases

Blood proteoforms may help predict liver transplant rejection

Effects of multi-nutrient supplementation on COVID-19 severity in elderly patients

Significance of metabolic parameters in COVID-19 prognosis

Drug combo delivered in a nanoparticle formulation extends the survival of mice with medulloblastoma

Music therapy can be an attractive option to manage menopause symptoms and depressed mood

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

Immunosuppressed patients can benefit from COVID-19 booster vaccination, study shows

Macromolecular gel with therapeutic payload could halt or slow post-traumatic osteoarthritis

Study provides a new treatment option for patients with relapsed B-cell lymphoma

Exploring hematological alterations in COVID-19 patients

SARS-CoV-2 Omicron variant found to display increased resilience to antiviral type I interferon response

Evaluating the use of megadoses of corticosteroids as a treatment of COVID-19

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News